3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
22
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Prostate Adenocarcinoma
2
Neoplasm Metastasis
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Salivary Gland Neoplasms
1
Primary Dysautonomias
1
Paget Disease, Extramammary
1
PSA Level Greater Than Two
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Kidney Diseases
1
Hypertension
1
Glioma
1
Glioblastoma
1
Carcinoma, Renal Cell
1
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
enzalutamide
3
darolutamide
2
abiraterone
2
pembrolizumab
1
bicalutamide
1
abemaciclib
1
Prednisolone
1
Goserelin
1
Docetaxel
1
AZD5305
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bulbo-Spinal Atrophy, X-Linked
×
bicalutamide
×
1 year
×
Clear all
NCT06365788
2026-04-01
ABBICAR
Universitaire Ziekenhuizen KU Leuven
Phase 2
Recruiting
53 enrolled